Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization

Betulinic acid (BA), a pentacyclic triterpene, represents a new therapeutic substance that has potential benefits for treating glioblastoma. Recently, new strategies for producing BA derivatives with improved properties have evolved. However, few studies have examined the combination of BA or BA der...

Descripción completa

Detalles Bibliográficos
Autores principales: Bache, Matthias, Bernhardt, Stephan, Passin, Sarina, Wichmann, Henri, Hein, Anja, Zschornak, Martin, Kappler, Matthias, Taubert, Helge, Paschke, Reinhard, Vordermark, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264138/
https://www.ncbi.nlm.nih.gov/pubmed/25361208
http://dx.doi.org/10.3390/ijms151119777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264138/
https://www.ncbi.nlm.nih.gov/pubmed/25361208
http://dx.doi.org/10.3390/ijms151119777

Ejemplares similares